DrMelpomeni Kalofonou
Advanced Research Fellow
Department of Electrical and Electronic Engineering - Faculty of Engineering
Orcid identifier0000-0001-8299-4106 (opens in a new tab)
- Advanced Research FellowDepartment of Electrical and Electronic Engineering - Faculty of Engineering
- 020 7594 1594 (Work)
- B420C - Centre for Bio-Inspired Technology (CBIT), Bessemer Building, South Kensington Campus, United Kingdom
RESEARCH
Research Interests
I am passionate about bringing technological innovations in Cancer Research by establishing and advancing the field of Cancer Technology, which I initiated and have been leading in CBIT for over 9 years. The convergence of Biomedical Engineering and Cancer Genetics is at the core, where I lead a multidisciplinary team focused on Cancer Diagnostics with a strong engineering background, aiming to address an impactful clinical application with a clearly defined translational vision.
Since my first appointment in 2014, I have been building unique expertise within the group, in the design of novel molecular diagnostics and electrochemical Lab-on-Chip systems for cancer using microchip technology, with an emphasis on liquid biopsies and the detection of tumour derived molecular markers for early detection of advanced disease, targeted monitoring and treatment stratification of cancer, with ongoing case studies and direct clinical translation in some of the most prevalent types of breast, colorectal, ovarian and prostate cancer with collaborations in the NHS.
I am passionate about bringing technological innovations in Cancer Research by establishing and advancing the field of Cancer Technology, which I initiated and have been leading in CBIT for over 9 years. The convergence of Biomedical Engineering and Cancer Genetics is at the core, where I lead a multidisciplinary team focused on Cancer Diagnostics with a strong engineering background, aiming to address an impactful clinical application with a clearly defined translational vision.
Since my first appointment in 2014, I have been building unique expertise within the group, in the design of novel molecular diagnostics and electrochemical Lab-on-Chip systems for cancer using microchip technology, with an emphasis on liquid biopsies and the detection of tumour derived molecular markers for early detection of advanced disease, targeted monitoring and treatment stratification of cancer, with ongoing case studies and direct clinical translation in some of the most prevalent types of breast, colorectal, ovarian and prostate cancer with collaborations in the NHS.